Home Hepatitis C in Egypt
Hepatitis C in Egypt PDF Print

In Egypt, the epidemiological and social situation differs from that of Western countries. HCV prevalence is very high (estimated among adults at 10 and 20% in urban and rural areas, respectively). The origin of the epidemic has been attributed to mass campaigns of parenteral anti-schistosomiasis treatment in rural areas in the 1960s–70s.

Since then, the virus has continued to spread, mainly through intravenous injections and other medical procedures. An important difference about the epidemic in Egypt is that >95% of infections are HCV genotype 4 (HCVg4). Currently, >8 million people infected with HCVg4 and the incidence of new infections remains the highest, worldwide.


To read this page in Arabic Please click here


SPHINX-HepaCute joint workshop EASL conference, London April 9th 2014


Sphinx researchers to translate biomarker discoveries onto point of care technologies in new FP7 project, PoC-HCV

About Sphinx
About Hepatitis C
News & Events
fp7 02
This project is
funded by the
European Union